JAYME HEIM: Open Payments
NPI 1992912836 · GRANDVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158,808 in 496 payments from 22 companies in 2025. Trend: 2023 $161,570 · 2024 $157,260 · 2025 $158,808
Speaker / faculty: $90,618Consulting: $30,123Travel & lodging: $25,727Food & beverage: $8,392Honoraria: $2,813Speaker / faculty: $1,028
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 55 | $45,853 |
| GENZYME CORPORATION | 49 | $24,372 |
| UCB, Inc. | 50 | $18,511 |
| Novartis Pharmaceuticals Corporation | 53 | $16,934 |
| Arcutis Biotherapeutics, Inc. | 27 | $11,780 |
| Galderma Laboratories, L.P. | 31 | $10,852 |
| Lilly USA, LLC | 26 | $10,689 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $4,729 |
| PFIZER INC. | 17 | $4,660 |
| LNHC, Inc | 4 | $2,943 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Zoryve, Rhapsido, NEMLUVIO, EBGLYSS, CIBINQO.
Industry payments across MI — which companies pay providers there.
